| __timestamp | Alpine Immune Sciences, Inc. | Axsome Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2287709 | 1392830 |
| Thursday, January 1, 2015 | 6844000 | 2419289 |
| Friday, January 1, 2016 | 8586000 | 6343648 |
| Sunday, January 1, 2017 | 6079000 | 7206691 |
| Monday, January 1, 2018 | 8362000 | 9351522 |
| Tuesday, January 1, 2019 | 9467000 | 13598030 |
| Wednesday, January 1, 2020 | 10899000 | 28896749 |
| Friday, January 1, 2021 | 14560000 | 66646205 |
| Saturday, January 1, 2022 | 17968000 | 159253661 |
| Sunday, January 1, 2023 | 22222000 | 323123000 |
| Monday, January 1, 2024 | 411359000 |
Igniting the spark of knowledge
In the competitive world of biotechnology, managing operational costs is crucial for success. This chart compares the Selling, General, and Administrative (SG&A) expenses of Axsome Therapeutics, Inc. and Alpine Immune Sciences, Inc. from 2014 to 2023. Over this period, Axsome Therapeutics has seen a dramatic increase in SG&A expenses, skyrocketing from approximately $1.4 million in 2014 to over $323 million in 2023. This represents a staggering growth of over 23,000%. In contrast, Alpine Immune Sciences experienced a more modest increase, with expenses rising from around $2.3 million to $22 million, marking a growth of nearly 860%. This divergence highlights the differing strategies and scales of these companies. Axsome's aggressive expansion is evident, while Alpine maintains a more conservative approach. Understanding these trends provides valuable insights into the financial strategies of biotech firms.
Selling, General, and Administrative Costs: Pfizer Inc. vs Axsome Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Genmab A/S and Axsome Therapeutics, Inc.
Selling, General, and Administrative Costs: Summit Therapeutics Inc. vs Alpine Immune Sciences, Inc.
SG&A Efficiency Analysis: Comparing Cytokinetics, Incorporated and Axsome Therapeutics, Inc.
Comparing SG&A Expenses: Alkermes plc vs Alpine Immune Sciences, Inc. Trends and Insights
Opthea Limited vs Alpine Immune Sciences, Inc.: SG&A Expense Trends
Research and Development Investment: Axsome Therapeutics, Inc. vs Alpine Immune Sciences, Inc.
Axsome Therapeutics, Inc. and Xenon Pharmaceuticals Inc.: SG&A Spending Patterns Compared
Axsome Therapeutics, Inc. and Catalyst Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Axsome Therapeutics, Inc. and MannKind Corporation
Alpine Immune Sciences, Inc. vs Bausch Health Companies Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Alpine Immune Sciences, Inc. vs Viridian Therapeutics, Inc. Trends and Insights